Latest papers

The expression, purification, and immunogenicity of a new chimeric virus-like particle.

Knowledge, Attitude, and Practice of Iranian Surgeons About Blood-Borne Diseases

Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.

Lay management of chronic disease: a qualitative study of living with hepatitis C infection.

Vaccination Against Hepatitis B and C: Towards Therapeutic Application

Bloodborne viral hepatitis infections among drug users: the role of vaccination.

[Progress on hepatitis E vaccine].

High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.

Hepatitis C vaccine: supply and demand.

Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large Veterans Administration Medical Centre.

Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus.

[Hepatitis over hepatitis. Its time for prevention].

Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvants.

[Hepatitis C virus vaccine].

[Development of oral vaccines].

Chronic fatigue syndrome with autoantibodies--the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant.

Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity.

Immunotherapy for HCV infection: next steps.

Synergistic effect of gene-electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination.

Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.